Frontal Assessment Battery and Differential Diagnosis of Frontotemporal Dementia and Alzheimer Disease

    loading  Checking for direct PDF access through Ovid


BackgroundThe different distribution of pathologic features in frontotemporal dementia (FTD) and Alzheimer disease (AD) predicts a predominant dysexecutive syndrome in FTD. The Frontal Assessment Battery (FAB) has previously been validated in diseases associated with a frontal lobe dysfunction.ObjectiveTo evaluate the sensitivity of the FAB to differentiate FTD and AD.DesignComparison study.SettingMemory Clinic of the Salpêtrière Hospital, Paris, France.PatientsTwenty-six patients with FTD and 64 patients with AD.Main Outcome MeasuresComparison of FAB and Mini-Mental State Examination (MMSE) scores between patients with FTD and those with AD.ResultsThe mean ± SD FAB scores significantly differed between patients with FTD (7.6 ± 4.2) and those with AD (12.6 ± 3.7) (P<.001), but not MMSE scores. The FAB correctly identified 78.9% of the patients. These results were maintained in a subgroup of mildly demented patients (MMSE score, ≥24). In these patients, a cutoff score of 12 on the FAB was optimal to differentiate both disorders (sensitivity, 77%; specificity, 87%).ConclusionsThe FAB takes less than 10 minutes to administer and provides an objective measure to distinguish FTD from AD in mildly demented patients.

    loading  Loading Related Articles